🔥 Our clinical trial of metronomic low-dose decitabine-ven in frontline MDS/ AML shows low tox, high efficacy & high response rate in TP53 mutant pts!! pubmed.ncbi.nlm.nih.gov/39316768/ Amit Verma Aditi Shastri, MD Ioannis Mantzaris Marina Konopleva Yogen Saunthararajah Montefiore Health System Albert Einstein College of Medicine - Official #leusm

🔥 Excited for our Phase 1 study Ven + 7+3 for Newly Diagnosed AML demonstrating 85% CR (86% MRD-neg) Blood Journal @ MontefioreNYC Albert Einstein College of Medicine - Official Montefiore Health System Eric J. Feldman Mendel Goldfinger Marina Konopleva Amit Verma Aditi Shastri, MD Kira Gritsman #leusm doi.org/10.1182/blood.…

Crispr modified CD70 allo CARs against T cell malignancies. Trial co-led by our outstanding Alex Sica in The Lancet Oncology Montefiore Health System Albert Einstein College of Medicine - Official thelancet.com/journals/lanon…